"Performance" WAI CHUN BIOTEC's mid-term loss narrowed to 5.94 million yuan
WAI CHUN BIOTEC (00660.HK) announced its interim results for the six months ending December 2025, with revenue of HKD 352 million, an increase of 118.7% year-on-year. The loss narrowed from HKD 13.66 million in the same period last year to HKD 5.94 million, with a loss per share of HKD 0.0333. No dividend was declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments